Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics.
about
The Trends of DMARDS prescribed in Rheumatoid Arthritis Patients in Malaysia.Framework for assessing quality of care for inflammatory bowel disease in Sweden.Time trends in medication use and expenditures in older patients with rheumatoid arthritisIdentifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations.Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugsDifferences between rheumatology attending physicians and training residents in the management of rheumatoid arthritis in Spain.A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis.Utilization patterns of disease-modifying antirheumatic drugs in elderly rheumatoid arthritis patientsDMARD non-use in low-income, elderly rheumatoid arthritis patients: results of 86 structured interviewsPhysician Preferences and Variations in Prescription of Biologic Drugs for Rheumatoid Arthritis: A Register-Based Study of 4,010 Patients in Sweden.Synthetic disease-modifying antirheumatic drug prescribing variability in rheumatoid arthritis: a multilevel analysis of a cross-sectional national study.Burden of rheumatoid arthritis in the Nordic region, 1990-2015: a comparative analysis using the Global Burden of Disease Study 2015.Neutropenia in the Elderly: A Rheumatology Perspective.Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment.Charting the possible impact of national guidelines on the management of rheumatoid arthritis.Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients.Healthcare Provider Type and Switch to Biologics in Psoriasis: Evidence from Real-World Practice.Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme?Trends in treatment strategies and the usage of different disease-modifying anti-rheumatic drugs in early rheumatoid arthritis in Finland. Results from a nationwide register in 2000-2007.A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs versus conventional therapy including DMARDs for patients without preference.
P2860
Q35627227-1E115A36-794F-4AE9-A674-D526A7DFBFB1Q35813211-EA9FF28B-2298-4B4F-A101-4568D7559EB0Q36204927-FA361C29-4BA2-40B0-9BA6-2FC7DFCC5AA6Q36836531-C598CA28-30EA-47E7-B315-94FDA381B363Q37147818-B161A7B1-5DF4-4BB8-923D-346973CE35E4Q37210077-C8DC0231-E074-4FEE-969C-4E14D8660202Q37546519-13C31DCB-60E1-4CD4-9D86-FFEB6F881B5DQ37583037-A0E0B721-DFCA-4606-BC6A-56927B355488Q37689767-846D4C43-D0B8-4A48-8D1C-769E267759D3Q38533964-06A463F4-C113-4C89-8DFC-30190660F4DFQ38592344-48DD74C5-FF24-40C1-AD8F-384C2DF95410Q38647394-DF95A6EE-39BB-4392-8BBD-95EDA527157BQ38893238-8973DF02-7F61-4E05-A5FD-93AB56682037Q40593579-FC6AF225-1999-4DD5-B058-3BB1D45288FEQ43992490-FB39D220-838F-436C-A63D-595B03E811E5Q44011924-5FB2DF0C-B06D-4940-BF58-A189DBBEDD56Q47883565-4C74D589-13C2-4242-8E73-6356141B026AQ50157070-B47C1224-8132-4C6B-BBDE-0E3C2B470383Q51546311-517499C8-D8EF-4F22-B968-9963BFC38131Q51733704-44D40301-A780-4F81-8EC2-0883F9C67CEC
P2860
Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Trends in disease modifying an ...... nt or disease characteristics.
@ast
Trends in disease modifying an ...... nt or disease characteristics.
@en
type
label
Trends in disease modifying an ...... nt or disease characteristics.
@ast
Trends in disease modifying an ...... nt or disease characteristics.
@en
prefLabel
Trends in disease modifying an ...... nt or disease characteristics.
@ast
Trends in disease modifying an ...... nt or disease characteristics.
@en
P2093
P2860
P356
P1476
Trends in disease modifying an ...... ent or disease characteristics
@en
P2093
P2860
P304
P356
10.1136/ARD.2004.027656
P407
P577
2005-12-01T00:00:00Z